XOOMAR

Cocrystal Pharma (COCP)

Cocrystal Pharma on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

179K

Short interest

settlement 2026-10-15

4.9

Days to cover

+1.7 days vs prior

17.4%

Short share of volume

2026-11-02

7,054

Fails to deliver

settlement 2026-10-14

Fri 13 Nov

Next earnings

estimated date

$10K

Insider flow, 90 days

1 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in COCP is 179,193 shares, down 143,555 shares over the last month. Over the last 48 readings it ranged from 673 shares (30 April 2025) to 988,346 shares (15 April 2026). At the reported average volume of 37K shares a day that is 4.9 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/cocp" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-15179,193+2.3%36,6264.89
2026-09-30175,246-45.7%54,3373.23
2026-09-15322,748+0.1%50,2396.42
2026-08-31322,544+4.9%61,5385.24
2026-08-14307,605-20.7%109,4492.81
2026-07-31388,004-1.8%27,41614.15
2026-07-15395,023-2.3%26,59114.86
2026-06-30404,505-1.4%90,4594.47
2026-06-15410,154+186.5%108,6943.77
2026-05-29143,168-25.7%130,7651.09
2026-05-15192,682-67.1%138,0141.40
2026-04-30586,422-40.7%189,0243.10
2026-04-15988,346+563.7%14,037,3421.00
2026-03-31148,911-30.5%50,3462.96
2026-03-13214,196-18.8%34,6986.17
2026-02-27263,840+11.8%45,6475.78
2026-02-13236,076+16.8%74,4273.17
2026-01-30202,066+26.0%66,8113.02
2026-01-15160,347+22.0%101,7791.58
2025-12-31131,425+3.1%88,2981.49
2025-12-15127,449-8.2%50,4242.53
2025-11-28138,793-21.3%74,2301.87
2025-11-14176,402-32.6%82,9902.13
2025-10-31261,762+5.8%242,6081.08
2025-10-15247,407-5.4%178,3441.39
2025-09-30261,648-73.3%524,4461.00
2025-09-15981,239+2282.2%8,510,7791.00
2025-08-2941,190+49.8%27,5201.50
2025-08-1527,491+2897.9%274,1191.00
2025-07-31917-55.9%34,5841.00
2025-07-152,080-53.5%31,7671.00
2025-06-304,470-6.1%16,7461.00
2025-06-134,760-65.3%27,9791.00
2025-05-3013,716+129.5%24,7001.00
2025-05-155,977+788.1%15,3811.00
2025-04-30673-89.0%15,8221.00
2025-04-156,146+316.1%18,2371.00
2025-03-311,477+2.1%17,2121.00
2025-03-141,446-91.0%17,4341.00
2025-02-2816,084+11.9%27,0691.00
2025-02-1414,367-12.4%38,5341.00
2025-01-3116,402-12.1%19,6841.00
2025-01-1518,661-33.1%48,7291.00
2024-12-3127,876+59.0%127,8651.00
2024-12-1317,532+149.3%16,1351.09
2024-11-297,032-12.2%14,3271.00
2024-11-158,011+303.0%31,5741.00
2024-10-311,988-94.5%21,2081.00

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of COCP volume is 17.4%, up 13.0 points over the last five sessions. Over the last 30 readings it ranged from 2.1% (12 October 2026) to 77.6% (24 September 2026). The latest reading is 13.0 points below the 30-session average of 30.4%, on 7K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-021K7K17.4%0
2026-10-3024K52K46.5%0
2026-10-293K10K28.9%0
2026-10-2814K28K50.9%0
2026-10-2734211K3.1%0
2026-10-2650211K4.4%0
2026-10-2315K31K50.0%0
2026-10-223K14K20.6%0
2026-10-218555K18.8%0
2026-10-204K11K34.2%2,050
2026-10-1922K103K21.3%7,554
2026-10-163K18K18.4%0
2026-10-1513K33K38.6%10,100
2026-10-144K21K20.8%0
2026-10-1324K53K45.6%0
2026-10-121045K2.1%0
2026-10-093053K11.6%0
2026-10-082K13K14.4%0
2026-10-076K22K28.6%400
2026-10-063K13K26.7%0
2026-10-059K31K29.5%0
2026-10-022K7K28.2%0
2026-10-016K21K30.7%0
2026-09-303K7K44.3%0
2026-09-2910K56K17.3%0
2026-09-283K20K14.1%0
2026-09-255K10K55.4%0
2026-09-2416K21K77.6%0
2026-09-239K16K55.2%0
2026-09-2212K21K56.3%0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 14 October 2026, the fails-to-deliver balance in COCP is 7,054 shares, up 6,700 shares over the last settlement date. Over the last 30 readings it ranged from 99 shares (9 September 2026) to 19,578 shares (4 August 2026).

SettlementShares failedPriceValue
2026-10-147,054$1.08$8K
2026-10-13354$1.06$375
2026-10-081,030$1.06$1K
2026-10-07300$1.11$333
2026-10-06360$1.11$400
2026-09-23200$1.19$238
2026-09-22297$1.19$353
2026-09-211,548$1.21$2K
2026-09-18435$1.14$496
2026-09-17787$1.14$897
2026-09-15388$1.17$454
2026-09-0999$1.18$117
2026-09-084,686$1.13$5K
2026-09-04190$1.13$215
2026-09-037,479$1.16$9K
2026-08-28215$1.14$245
2026-08-271,390$1.12$2K
2026-08-202,505$1.15$3K
2026-08-141,575$1.10$2K
2026-08-13135$1.12$151
2026-08-121,099$1.08$1K
2026-08-1116,046$1.08$17K
2026-08-071,379$1.03$1K
2026-08-065,378$1.02$5K
2026-08-0518,725$0.98$18K
2026-08-0419,578$0.94$18K
2026-07-311,286$0.86$1K
2026-07-291,991$0.93$2K
2026-07-27727$0.90$654
2026-07-17428$0.95$407

Insider trades

SEC Form 4, newest first. JSON

Insiders at COCP reported 1 open-market buy worth $10K in the last 90 days and no open-market sells. Latest filing: FROST PHILLIP MD ET AL (Director, 10% owner) on 2026-08-05.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-08-05FROST PHILLIP MD ET ALDirector, 10% ownerBuy10K$0.98$10K2.0M
2026-08-03FROST PHILLIP MD ET ALDirector, 10% ownerBuy75K$0.94$71K2.0M
2026-02-24FROST PHILLIP MD ET ALDirector, 10% ownerBuy20K$1.00$20K1.9M
2026-02-06FROST PHILLIP MD ET ALDirector, 10% ownerBuy50K$0.95$47K1.9M
2025-12-31FROST PHILLIP MD ET ALDirector, 10% ownerBuy50K$0.95$47K1.8M
2025-12-30FROST PHILLIP MD ET ALDirector, 10% ownerBuy20K$0.97$19K1.8M
2025-12-26FROST PHILLIP MD ET ALDirector, 10% ownerBuy40K$0.97$39K1.8M
2025-12-24FROST PHILLIP MD ET ALDirector, 10% ownerBuy25K$0.97$24K1.7M
2025-11-26FROST PHILLIP MD ET ALDirector, 10% ownerBuy3K$0.99$2K1.7M
2025-11-26FROST PHILLIP MD ET ALDirector, 10% ownerBuy2K$1.00$2K1.7M
2025-11-25FROST PHILLIP MD ET ALDirector, 10% ownerBuy20K$0.94$19K1.7M
2025-10-28PFENNIGER RICHARD C JRDirectorGrant20Kprice not stated in the filingnot stated31K
2025-10-28FROST PHILLIP MD ET ALDirector, 10% ownerGrant360K$1.39$500K1.7M
2025-10-28Hassan FredDirectorGrant360K$1.39$500K1.4M
2025-10-28Martin James JosephCo-CEO and CFOGrant4K$1.39$5K44K
2024-10-09Martin James JosephCo-CEO and CFOGrant40Kprice not stated in the filingnot stated41K
2024-10-09Rubin Steven DDirectorGrant19Kprice not stated in the filingnot stated2.7M
2024-10-09Kornberg Roger D.DirectorGrant28Kprice not stated in the filingnot stated28K
2024-10-09FROST PHILLIP MD ET ALDirector,TenPercentOwnerGrant27Kprice not stated in the filingnot stated27K
2024-10-09Lee SamPresident and Co-CEOGrant40Kprice not stated in the filingnot stated76K
2024-10-09PFENNIGER RICHARD C JRDirectorGrant8Kprice not stated in the filingnot stated11K
2024-10-09Japour Anthony JDirectorGrant15Kprice not stated in the filingnot stated15K
2024-10-09Hassan FredDirectorGrant8Kprice not stated in the filingnot stated1.0M
2023-04-04FROST PHILLIP MD ET ALDirector,TenPercentOwnerBuy1.0M$1.97$2.0M1.3M
2021-08-20PFENNIGER RICHARD C JRDirectorBuy40K$1.03$41K40K
2021-05-04Schinazi Raymond FTenPercentOwnerSell575K$2.95$1.7M7.7M

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

5 holders report 5% or more of COCP in their latest filing, all on Schedule 13D (active intent). The largest reported stake is OPKO HEALTH, INC. at 29.6% of the class (5,692,916 shares), filed 2026-08-07 for an event on 2026-07-31.

FiledFormHolderSharesOf classEvent
2026-08-0713D/Ano. 8Phillip Frost, M.D.individual2.8M13.9%2026-08-03
2026-08-0713D/Ano. 8Frost Gamma Investments Trustother entity2.7M13.5%2026-08-03
2026-08-0713DOPKO HEALTH, INC.corporation5.7M29.6%2026-07-31
2026-08-0713DRubin Steven Dindividual2.7M14.1%2026-07-31
2026-08-0713DFROST PHILLIP MD ET ALindividual2.8M13.9%2026-07-31

13F holders

Tracked managers holding COCP at their latest 13F. JSON

3 of the 30 tracked managers held COCP at their latest 13F, $420K in total at quarter-end prices. Renaissance Technologies is the largest at $189K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 0 cut.

FundQuarterSharesValueOf portfolioChange in shares
Renaissance Technologies2026-06-30180K$189K0.00%+56K
Two Sigma Investments2026-06-30175K$184K0.00%new
Citadel Advisors2026-06-3045K$47K0.00%new

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Cocrystal Pharma in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Cocrystal Pharma (COCP), SEC CIK 1412486, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-07.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-03-31.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-05.JSON and CSV
Company record
EDGAR filing index for CIK 1412486Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of COCP is sold short?
179,193 shares were held short at the 2026-10-15 settlement, 4.9 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is COCP's daily short volume?
On 2026-11-02, 1,158 of the 6,646 COCP shares reported to FINRA were sold short, 17.4% of the day's reported volume. Short volume is a flow for one day, not a position.
Does COCP have fails to deliver?
The SEC's latest file shows 7,054 COCP shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.
Are COCP insiders buying or selling?
Insiders at COCP reported 1 open-market buy worth $10K in the last 90 days and no open-market sells. Latest filing: FROST PHILLIP MD ET AL (Director, 10% owner) on 2026-08-05.
Who owns 5% or more of COCP?
5 holders report 5% or more of COCP in their latest filing, all on Schedule 13D (active intent). The largest reported stake is OPKO HEALTH, INC. at 29.6% of the class (5,692,916 shares), filed 2026-08-07 for an event on 2026-07-31.
Which tracked 13F managers own COCP?
3 of the 30 tracked 13F managers held COCP shares at their latest filing, $420K in all. The largest: Renaissance Technologies (180K shares, $189K), Two Sigma Investments (175K shares, $184K), Ken Griffin's Citadel Advisors (45K shares, $47K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.